Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular mechanisms of CD4+ T-cell anergy.
Fathman CG, Lineberry NB. Fathman CG, et al. Among authors: lineberry nb. Nat Rev Immunol. 2007 Aug;7(8):599-609. doi: 10.1038/nri2131. Epub 2007 Jul 6. Nat Rev Immunol. 2007. PMID: 17612584 Review.
T cell anergy: where it's LAT.
Lineberry N, Fathman CG. Lineberry N, et al. Immunity. 2006 May;24(5):501-3. doi: 10.1016/j.immuni.2006.05.002. Immunity. 2006. PMID: 16713965 Free article. Review.
CYLD: deubiquitination-induced TCR signaling.
Lineberry N, Fathman CG. Lineberry N, et al. Nat Immunol. 2006 Apr;7(4):369-70. doi: 10.1038/ni0406-369. Nat Immunol. 2006. PMID: 16550202 No abstract available.
Challenges in IBD Research: Novel Technologies.
Dhyani M, Joshi N, Bemelman WA, Gee MS, Yajnik V, D'Hoore A, Traverso G, Donowitz M, Mostoslavsky G, Lu TK, Lineberry N, Niessen HG, Peer D, Braun J, Delaney CP, Dubinsky MC, Guillory AN, Pereira M, Shtraizent N, Honig G, Polk DB, Hurtado-Lorenzo A, Karp JM, Michelassi F. Dhyani M, et al. Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S24-S30. doi: 10.1093/ibd/izz077. Inflamm Bowel Dis. 2019. PMID: 31095703 Free PMC article. Review.
Activation of Tumor-Cell STING Primes NK-Cell Therapy.
Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, Ozgenc I, Noureddine M, Meisenheimer B, Chen M, Piel B, Spicer N, Obua B, Messier CM, Shannon E, Mahadevan NR, Tani T, Schol PJ, Lee-Hassett AM, Zlota A, Vo HV, Ha M, Bertram AA, Han S, Thai TC, Gustafson CE, Venugopal K, Haggerty TJ, Albertson TP, Hartley AV, Eser PO, Li ZH, Cañadas I, Vivero M, De Rienzo A, Richards WG, Abu-Yousif AO, Appleman VA, Gregory RC, Parent A, Lineberry N, Smith EL, Jänne PA, Miret JJ, Tolstorukov MY, Romee R, Paweletz CP, Bueno R, Barbie DA. Knelson EH, et al. Cancer Immunol Res. 2022 Aug 3;10(8):947-961. doi: 10.1158/2326-6066.CIR-22-0017. Cancer Immunol Res. 2022. PMID: 35678717 Free PMC article.
12 results